Efficacy of Natural Immunity against SARS-CoV-2 Reinfection with the Beta Variant
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2021 |
|---|---|
| Erschienen: |
2021 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:385 |
|---|---|
| Enthalten in: |
The New England journal of medicine - 385(2021), 27 vom: 30. Dez., Seite 2585-2586 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Chemaitelly, Hiam [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
|---|
| Anmerkungen: |
Date Completed 12.01.2022 Date Revised 23.11.2023 published: Print-Electronic Citation Status MEDLINE |
|---|
| doi: |
10.1056/NEJMc2110300 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM334471168 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM334471168 | ||
| 003 | DE-627 | ||
| 005 | 20231225223748.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231225s2021 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1056/NEJMc2110300 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1114.xml |
| 035 | |a (DE-627)NLM334471168 | ||
| 035 | |a (NLM)34910864 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Chemaitelly, Hiam |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Efficacy of Natural Immunity against SARS-CoV-2 Reinfection with the Beta Variant |
| 264 | 1 | |c 2021 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 12.01.2022 | ||
| 500 | |a Date Revised 23.11.2023 | ||
| 500 | |a published: Print-Electronic | ||
| 500 | |a Citation Status MEDLINE | ||
| 650 | 4 | |a Letter | |
| 650 | 4 | |a Research Support, Non-U.S. Gov't | |
| 650 | 7 | |a Antibodies, Viral |2 NLM | |
| 700 | 1 | |a Bertollini, Roberto |e verfasserin |4 aut | |
| 700 | 1 | |a Abu-Raddad, Laith J |e verfasserin |4 aut | |
| 700 | 0 | |a National Study Group for COVID-19 Epidemiology |e verfasserin |4 aut | |
| 700 | 1 | |a Abu Raddad, Laith J |e investigator |4 oth | |
| 700 | 1 | |a Chemaitelly, Hiam |e investigator |4 oth | |
| 700 | 1 | |a Malek, Joel A |e investigator |4 oth | |
| 700 | 1 | |a Benslimane, Fatiha M |e investigator |4 oth | |
| 700 | 1 | |a Al Khatib, Hebah A |e investigator |4 oth | |
| 700 | 1 | |a Yassine, Hadi M |e investigator |4 oth | |
| 700 | 1 | |a Ayoub, Houssein H |e investigator |4 oth | |
| 700 | 1 | |a Abdul Rahim, Hanan F |e investigator |4 oth | |
| 700 | 1 | |a Nasrallah, Gheyath K |e investigator |4 oth | |
| 700 | 1 | |a Butt, Adeel A |e investigator |4 oth | |
| 700 | 1 | |a Coyle, Peter |e investigator |4 oth | |
| 700 | 1 | |a Jeremijenko, Andrew |e investigator |4 oth | |
| 700 | 1 | |a Al Kanaani, Zaina |e investigator |4 oth | |
| 700 | 1 | |a Al Khal, Abdullatif |e investigator |4 oth | |
| 700 | 1 | |a Kuwari, Einas Al |e investigator |4 oth | |
| 700 | 1 | |a Kaleeckal, Anvar H |e investigator |4 oth | |
| 700 | 1 | |a Latif, Ali Nizar |e investigator |4 oth | |
| 700 | 1 | |a Shaik, Riyazuddin M |e investigator |4 oth | |
| 700 | 1 | |a Tang, Patrick |e investigator |4 oth | |
| 700 | 1 | |a Hasan, Mohammad R |e investigator |4 oth | |
| 700 | 1 | |a Al Kuwari, Mohamed Ghaith |e investigator |4 oth | |
| 700 | 1 | |a Bertollini, Roberto |e investigator |4 oth | |
| 700 | 1 | |a Al Romaihi, Hamad Eid |e investigator |4 oth | |
| 700 | 1 | |a Al Thani, Mohamed H |e investigator |4 oth | |
| 773 | 0 | 8 | |i Enthalten in |t The New England journal of medicine |d 1945 |g 385(2021), 27 vom: 30. Dez., Seite 2585-2586 |w (DE-627)NLM000008184 |x 1533-4406 |7 nnns |
| 773 | 1 | 8 | |g volume:385 |g year:2021 |g number:27 |g day:30 |g month:12 |g pages:2585-2586 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1056/NEJMc2110300 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 385 |j 2021 |e 27 |b 30 |c 12 |h 2585-2586 | ||